## LVS: Las Vegas Sands Corp. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_10 -2.9% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-5.9% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($62.73)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. One Fortune 500 Company is Making a Big Bet on the Future of Texas Gambling**
- Source: www.sharewise.com | 20251203T033716 | Neutral | Relevance: 99%
- Las Vegas Sands Corporation, a Fortune 500 company, is significantly increasing its investment and presence in Texas despite the state's current legal restrictions on gambling. This aggressive strategy includes real estate purchases near Dallas and the acquisition of a majority stake in the NBA's Dallas Mavericks, with plans for a new arena and casino complex. While Texas casino legalization faces an uphill battle and recent political setbacks, Las Vegas Sands appears committed to a long-term strategy, betting on eventual legislative change.

**2. Patrick Dumont Sells 17,352 Shares of Las Vegas Sands (NYSE:LVS) Stock**
- Source: MarketBeat | 20251205T021024 | Neutral | Relevance: 99%
-  Patrick Dumont, COO of Las Vegas Sands (NYSE:LVS), sold 17,352 shares of the company's stock on December 2nd for approximately $1.20 million, reducing his stake by 3.74%. This follows a larger sale of 210,305 shares on December 1st for $14.71 million. The stock traded down 2.3% to $66.95 after these transactions, yet analysts maintain a "Moderate Buy" rating with an average target price of $65.60.

**3. Las Vegas Sands Corp. stock outperforms market despite losses on the day**
- Source: MarketWatch | 20251203T165000 | Neutral | Relevance: 99%
-  Las Vegas Sands Corp. (LVS) shares dropped 2.38% to $66.88 on Wednesday, marking its second consecutive day of losses. Despite this decline, the stock still outperformed the broader market, which saw the S&P 500 Index and Dow Jones Industrial Average rise by 0.30% and 0.86% respectively.

**4. Insider Selling: Las Vegas Sands (NYSE:LVS) EVP Sells $3,747,695.09 in Stock**
- Source: MarketBeat | 20251205T023708 | Neutral | Relevance: 99%
-  Las Vegas Sands EVP D. Zachary Hudson recently sold 53,257 shares for $3,747,695.09 and an additional 100,000 shares for $6,499,000.00, significantly reducing his stake in the company. Despite the insider selling, Las Vegas Sands reported stronger-than-expected Q3 earnings with $0.78 EPS and $3.33 billion in revenue, leading analysts to maintain a "Moderate Buy" rating with an average target price of $65.60. The company also declared a quarterly dividend of $0.25, paid in November.

**5. VP Hudson Sells 53,257 ($3.7M) Of Las Vegas Sands Corp [LVS]**
- Source: TradingView | 20251204T200749 | Neutral | Relevance: 98%
-  VP Hudson of Las Vegas Sands Corp (LVS) sold 53,257 shares totaling $3.7 million on December 1, 2025, after exercising options worth $3.07 million. This transaction was disclosed in a Form 4 filed with the SEC on December 3, 2025, and leaves Hudson with 13,735 direct holdings.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | UBS | $68 | $67 | +1% |
| 2025-12-01 | Argus Research | $80 | $65 | +23% |
| 2025-11-18 | Wells Fargo | $66 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | UBS | main | Neutral |
| 2025-12-01 | Argus Research | main | Buy |
| 2025-11-18 | Wells Fargo | init | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($13.25M) |
| Sells | 12 ($64.93M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 24.9% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 8 |

**Top Holders:**
- Vanguard Group Inc: 6.2% (-2.0%)
- Capital Research Glo: 5.0% (-30.9%)
- Blackrock Inc.: 4.0% (-0.1%)
- Price (T.Rowe) Assoc: 2.2% (-7.8%)
- State Street Corpora: 2.1% (-7.2%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-5.9% 5d) with bearish MACD, trend may be turning.
2. Heavy insider selling: $65M sold (12 transactions in 90 days).
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.86 indicates undervaluation relative to growth. Forward P/E 20.8x stretched relative to 10% growth. Quality metrics strong (ROE 66%). Analyst sentiment positive (2 raises, avg +12%). Insider selling cluster ($64.9M in 90 days), potential headwind. Institutional flow bearish (8 selling vs 2 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $45.6B |
| Beta | 0.97 |
| 52W Range | $30.18 - $70.45 |
| Short Interest | 2.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.86 |
| Forward P/E | 20.8 |
| Current P/E | 22.8 |
| YoY Growth | 9.6% |
| EPS Direction | RISING |

### Technicals

MRS_10 deteriorating from 3.0% to -2.9% (-5.9% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.9pp (needs >3.0% for momentum thesis). Underperforming sector by 3.4pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.36x) but short-term weakness (below SMA20). RSI neutral at 59.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -2.94% (CS: 23) | Weak |
| RSI_14 | 58.7 | Neutral |
| MACD Histogram | -0.39 | Bearish |
| vs SMA20 | 1.000x | Below |
| vs SMA50 | 1.120x | Above |
| vs SMA200 | 1.361x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $66.25
- **Stop Loss:** $62.73 (5.3% risk)
- **Target:** $69.77 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 284
- **Position Value:** $18,815.00
- **Portfolio %:** 18.82%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite persisting. Mixed earnings signals with industrial weakness (John Deere) offset by consumer/tech strength, while institutional flows show selective positioning rather than broad risk-off. Fed meeting in 9 days provides near-term catalyst but current data suggests status quo maintenance.*

### Earnings

**Next:** 2026-01-28 (Est: $0.75)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.62 | $0.78 | +25.4% |
| 2025Q2 | $0.53 | $0.79 | +48.9% |
| 2025Q1 | $0.57 | $0.59 | +3.8% |
| 2024Q4 | $0.58 | $0.54 | -6.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*